Edition:
United States

Agios Pharmaceuticals Inc (AGIO.O)

AGIO.O on Nasdaq

54.09USD
17 Feb 2017
Change (% chg)

$4.26 (+8.55%)
Prev Close
$49.83
Open
$49.86
Day's High
$54.23
Day's Low
$49.09
Volume
1,137,186
Avg. Vol
771,168
52-wk High
$67.74
52-wk Low
$34.31

AGIO.O

Chart for AGIO.O

About

Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery and development of orally available small molecule medicines for the treatment of cancer and rare genetic disorders (RGDs), which are a subset of orphan genetic metabolic diseases. Its cancer product candidates are AG-221 and... (more)

Overall

Beta: 2.10
Market Cap(Mil.): $2,272.58
Shares Outstanding(Mil.): 42.01
Dividend: --
Yield (%): --

Financials

  AGIO.O Industry Sector
P/E (TTM): -- 47.80 29.39
EPS (TTM): -5.06 -- --
ROI: -44.21 -4.08 13.06
ROE: -56.41 4.84 14.19

BRIEF-Agios says cash, marketable securities were $573.6 mln as of Dec. 31

* Agios reports fourth quarter and full year 2016 financial results and highlights key 2017 milestones

Feb 16 2017

BRIEF-Agios pharmaceuticals AG-120 NDA submission for IDH1M R/R AML planned by year end 2017

* AG-120 NDA submission for IDH1M R/R AML planned by year end 2017

Jan 09 2017

BRIEF-Agios provides early-stage data on AG-120 in glioma, chondrosarcoma patients

* Agios announces phase 1 data from dose expansion cohorts of AG-120 in patients with IDH1 mutant positive glioma and chondrosarcoma Source text for Eikon: Further company coverage:

Nov 18 2016

BRIEF-Agios posts Q3 shr loss $1.63

* Agios Pharmaceuticals inc - now expects to end 2016 with more than $550 million of cash, cash equivalents and marketable securities

Nov 03 2016

BRIEF-Agios Pharma says Celgene expects to submit NDA to U.S. FDA for enasidenib

* Celgene corporation expects to submit a new drug application to U.S. FDA for Enasidenib (ag-221)

Sep 07 2016

More From Around the Web

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $33.62 0.00
Novartis AG (NOVN.S) CHF76.80 -0.20
Roche Holding Ltd. (ROG.S) CHF244.50 +1.00
Roche Holding Ltd. (RO.S) CHF247.80 +1.50
Sanofi SA (SASY.PA) €81.06 -0.43
AstraZeneca plc (AZN.L) 4,584.00 -11.00
GlaxoSmithKline plc (GSK.L) 1,634.00 -5.50
Eli Lilly and Co (LLY.N) $80.39 +0.35
Shire PLC (SHP.L) 4,823.50 -12.50
Shire PLC (3159084.L) -- --

Earnings vs. Estimates